209 related articles for article (PubMed ID: 21944962)
1. Renal crescentic alpha heavy chain deposition disease: a report of 3 cases and review of the literature.
Alexander MP; Nasr SH; Watson DC; Méndez GP; Rennke HG
Am J Kidney Dis; 2011 Oct; 58(4):621-5. PubMed ID: 21944962
[TBL] [Abstract][Full Text] [Related]
2. Heavy chain deposition disease: recurrence in a renal transplant and report of IgG(2) subtype.
Herzenberg AM; Kiaii M; Magil AB
Am J Kidney Dis; 2000 May; 35(5):E25. PubMed ID: 10793054
[TBL] [Abstract][Full Text] [Related]
3. A unique case of γ-heavy chain deposition disease characterized by concomitant deposition of γ2 and γ4 subclasses.
Yin G; Wu Y; Zeng CH; Chen HP; Liu ZH
Intern Med; 2014; 53(22):2615-8. PubMed ID: 25400185
[TBL] [Abstract][Full Text] [Related]
4. Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management.
Bridoux F; Javaugue V; Bender S; Leroy F; Aucouturier P; Debiais-Delpech C; Goujon JM; Quellard N; Bonaud A; Clavel M; Trouillas P; Di Meo F; Gombert JM; Fermand JP; Jaccard A; Cogné M; Touchard G; Sirac C
Kidney Int; 2017 Feb; 91(2):423-434. PubMed ID: 27773425
[TBL] [Abstract][Full Text] [Related]
5. Cutis laxa for diagnosis of γ1-heavy-chain deposition disease: Report of four cases.
Chavarot N; Battistella M; Vignon M; Baron M; Girerd S; Jachiet M; Asli B; Galicier L; Malphettes M
J Dermatol; 2018 Oct; 45(10):1211-1215. PubMed ID: 30035313
[TBL] [Abstract][Full Text] [Related]
6. IgG heavy-chain deposition disease.
Katz A; Zent R; Bargman JM
Mod Pathol; 1994 Oct; 7(8):874-8. PubMed ID: 7838842
[TBL] [Abstract][Full Text] [Related]
7. Heavy Chain Deposition Disease: Clinicopathologic Characteristics of a Chinese Case Series.
Zhang Y; Li X; Liang D; Xu F; Liang S; Zhu X; Zheng N; Huang X; Liu Z; Zeng C
Am J Kidney Dis; 2020 May; 75(5):736-743. PubMed ID: 31699519
[TBL] [Abstract][Full Text] [Related]
8. A case of renal γ2 heavy-chain deposition disease accompanied by rapid progressive renal failure.
Chen GT; Liao XH; Yan RY; Li Y; Zhang L
Ir J Med Sci; 2014 Jun; 183(2):319-21. PubMed ID: 23963539
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal immunoglobulins.
Franklin EC
Ann Clin Lab Sci; 1980; 10(3):181-6. PubMed ID: 6772084
[TBL] [Abstract][Full Text] [Related]
10. Use of bortezomib in heavy-chain deposition disease: a report of 3 cases.
Patel K; Dillon JJ; Leung N; Bomback AS; Appel GB; D'Agati V; Canetta PA
Am J Kidney Dis; 2014 Jul; 64(1):123-7. PubMed ID: 24613055
[TBL] [Abstract][Full Text] [Related]
11. Acquired cutis laxa associated with heavy chain deposition disease.
Harrington CR; Beswick TC; Susa JS; Pandya AG
J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S99-101. PubMed ID: 19119136
[TBL] [Abstract][Full Text] [Related]
12. The combination of thrombotic microangiopathy and nodular sclerosis in light chain deposition disease.
Kanjanabuch T; Bunruang R; Srisawat N; Lewsuwan S; Kittikovit V; Eiam-Ong S
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S248-52. PubMed ID: 17044479
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin gamma3-heavy-chain deposition disease: report of a case and relationship with hypocomplementemia.
Soma J; Sato K; Sakuma T; Saito H; Sato H; Sato T; Abbas A; Aucouturier P
Am J Kidney Dis; 2004 Jan; 43(1):E10-6. PubMed ID: 14712467
[TBL] [Abstract][Full Text] [Related]
14. Proliferative glomerulonephritis with discrete deposition of monoclonal immunoglobulin γ1 CH 2 heavy chain and κ light chain: a new variant of monoclonal immunoglobulin deposition disease.
Komatsuda A; Ohtani H; Sawada K; Joh K; Wakui H
Pathol Int; 2013 Jan; 63(1):63-7. PubMed ID: 23356227
[TBL] [Abstract][Full Text] [Related]
15. Clinical remission and histopathological resolution of nodular lesions in a patient with gamma3 heavy-chain deposition disease.
Soma J; Tsuchiya Y; Sakuma T; Sato H
Clin Nephrol; 2008 May; 69(5):383-6. PubMed ID: 18538103
[TBL] [Abstract][Full Text] [Related]
16. Generalized acquired cutis laxa associated with multiple myeloma with biphenotypic IgG-λ and IgA-κ gammopathy following treatment of a nodal plasmacytoma.
New HD; Callen JP
Arch Dermatol; 2011 Mar; 147(3):323-8. PubMed ID: 21422340
[TBL] [Abstract][Full Text] [Related]
17. Gamma heavy chain "disease": heterogeneity of the clinicopathologic features. Report of 16 cases and review of the literature.
Fermand JP; Brouet JC; Danon F; Seligmann M
Medicine (Baltimore); 1989 Nov; 68(6):321-35. PubMed ID: 2509855
[TBL] [Abstract][Full Text] [Related]
18. Acquired cutis laxa associated with heavy chain deposition disease involving dermal elastic fibers.
O'Malley JT; D'Agati VD; Sherman WH; Grossman ME
JAMA Dermatol; 2014 Nov; 150(11):1192-6. PubMed ID: 25133950
[TBL] [Abstract][Full Text] [Related]
19. Bortezomib successfully reverses early recurrence of light-chain deposition disease in a renal allograft: a case report.
Kaposztas Z; Kahan BD; Katz SM; Van Buren CT; Cherem L
Transplant Proc; 2009 Dec; 41(10):4407-10. PubMed ID: 20005409
[TBL] [Abstract][Full Text] [Related]
20. Hematologic response and stabilization of renal function in a patient with light chain deposition disease after lenalidomide treatment: a novel therapeutic approach?
Gkotzamanidou M; Terpos E; Kastritis E; Dimopoulos MA
Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):e179-81. PubMed ID: 25022598
[No Abstract] [Full Text] [Related]
[Next] [New Search]